Varian Medical Systems (NYSE: VAR)stock identified change of 15.75% away from 52-week low price and recently located move of -17.62% off 52-week high price. It has market worth of $10682.49M . VAR stock has been recorded -0.92% away from 50 day moving average and -7.70% away from 200 day moving average. Moving closer, we can see that shares have been trading 8.23% off 20-day moving average.
Varian (NYSE: VAR) announced it is investing in Oncora Medical and partnering to accelerate the development of software tools to enable precision medicine in radiation oncology. Oncora is a privately-held digital health company using software and data to equip doctors and scientists with analytics tools to develop the optimal cancer treatment plan for each patient.
Oncora Patient Care™, the company’s documentation, workflow, and decision support solution, was developed in conjunction with oncologists at MD Anderson Cancer Center and helps capture critical data about cancer patients, their treatments, and their clinical outcomes so that doctors can learn from past experience to improve care for patients.
Oncora’s predictive modeling engine encodes this knowledge in computational models that can accurately predict the outcomes of new patients’ treatments. Varian and Oncora plan to use these predictive models to help doctors design treatments for patients that minimize their risk of toxicity and maximize their chance for cure. Oncora Analytics™, the company’s research engine, aggregates longitudinal data on prior patients and makes this real-world data available to power scientific and medical research. The software is in use at 13 sites of care across the United States.
“We envision a world where all patients have access to the highest quality cancer care regardless of their location,” said Corey Zankowski, senior vice president of Varian Oncology Software Solutions. “Oncora Medical’s ability to aggregate vast amounts of patient data is designed to empower oncologists with a decision support tool to achieve the goal of elevating the standard of care across the country.”
“Oncora’s mission is to improve outcomes for cancer patients by developing intuitive software tools to better collect and learn from real world data,” said David Lindsay, Oncora co-founder and chief executive officer. “We look forward to partnering with Varian to develop and deploy innovative new tools in the fight against cancer.”
The Healthcare sector company, Varian Medical Systems noticed change of -1.81% to $117.39 along volume of 1263341 shares in recent session compared to an average volume of 676.82K. The stock observed return of 7.16% in 5 days trading activity. The stock was at 9.17% over one month performance. VAR’s shares are at -10.31% for the quarter and driving a 6.98% return over the course of the past year and is now at 3.60% since this point in 2018.
The average volatility for the week at 3.27% and for month was at 2.18%. There are 91M shares outstanding and 90.8M shares are floated in market. Right now the stock beta is 0.86.
Marcus Miller writes for Finance section of website. He has been a freelance journalist for 8 years, contributing to different online publications. Marcus graduated from University with a BBA in Management with a concentration in Consulting and Business Analysis. In his free time, he likes to indulge in outdoor activities, binge watch HBO GO series and catch local bands playing. He is currently based in USA, and can be reached at [email protected].
ADDRESS # 3428 Wild Heron Way, Panama City Beach, FL 32413, USA
CONTACT # 850-867-3182
